share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  07/24 12:30

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/24/2024, with an aggregate market value of $1,113,688.80. The shares to be sold were acquired through restricted stock vesting on 02/20/2024 and 02/24/2024, as part of compensation from the issuer. Over the past three months, a total of 9,120 shares have been sold by the officer, generating gross proceeds of $4,292,375.60.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/24/2024, with an aggregate market value of $1,113,688.80. The shares to be sold were acquired through restricted stock vesting on 02/20/2024 and 02/24/2024, as part of compensation from the issuer. Over the past three months, a total of 9,120 shares have been sold by the officer, generating gross proceeds of $4,292,375.60.
Vertex Pharmaceuticals Inc. 官員 Carmen Bozic 擬於2024年07月24日出售 2,280 股普通股,市值合計 1,113,688.80 美元。即將出售的股份是作爲發行方補償的一部分,在 2024年02月20日和2024年02月24日通過限制股票獲得。在過去的三個月中,官員共出售了 9,120 股,總收入爲 4,292,375.60 美元。
Vertex Pharmaceuticals Inc. 官員 Carmen Bozic 擬於2024年07月24日出售 2,280 股普通股,市值合計 1,113,688.80 美元。即將出售的股份是作爲發行方補償的一部分,在 2024年02月20日和2024年02月24日通過限制股票獲得。在過去的三個月中,官員共出售了 9,120 股,總收入爲 4,292,375.60 美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息